Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting

Reduced ability to neutralize the Omicron variant among adults after infection and complete vaccination with BNT162b2, ChAdOx1, or CoronaVac and heterologous boosting

Abstract COVID-19 vaccines have dramatically reduced rates of severe infection requiring hospitalization. However, SARS-CoV-2 variants have reduced vaccine effectiveness at preventing any symptomatic infection. This real-world study analyzed binding and neutralizing antibodies generated after comple...

Full description

Bibliographic Details
Main Authors: Otávio Melo Espíndola, Trevon L. Fuller, Mia Ferreira de Araújo, Luis Fernando Lopez Tort, Lusiele Guaraldo, Guilherme Calvet, Paola Resende, Myrna Bonaldo, Jimmy Whitworth, Chris Smith, Marilda Siqueira, Patrícia Brasil
Format: Article
Language:English
Published: Nature Portfolio 2023-05-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-34035-9

Internet

https://doi.org/10.1038/s41598-023-34035-9

Similar Items